Colossal, which has raised at least $435 million since it was founded by Lamm and Harvard University geneticist George Church in 2021, has committed “a large investment” to New Zealand, the company ...

Colossal Biosciences has announced its first acquisition, bringing Viagen Pets and Equine, the world leader in animal cloning, into its growing biotechnology family. Viagen made headlines a few years ...

“I’m excited,” Beth Shapiro, Colossal’s chief science officer, told PEOPLE in an exclusive interview in March. She described the mouse as “really our first validation” that the company can ...

This business acquisition appears to be a genetic match: Colossal Biosciences, the company that brought back the dire wolves, has acquired Viagen Pets and Equine, which has cloned dogs for Paris ...

Actress Sophie Turner, best known for her iconic role as Sansa Stark on "Game of Thrones," swapped her medieval kingdom for a cutting-edge adventure in biotech at this year’s SXSW London. As a member ...

A Texas genetics company working to bring back the woolly mammoth says it’s a step closer to reviving another famed extinct species: the dodo. Dallas-based Colossal Biosciences Inc. said Wednesday it ...

In collaboration with conservation juggernaut Re:wild, Colossal’s Fund sets a new standard for wildlife restoration The Colossal Foundation, the 501(c)(3) charitable organization of Colossal ...

Long-term partnership with the Turner Endangered Species Fund advances North America’s most successful Pleistocene rewilding success story The Colossal Foundation, the 501(c)(3) charitable ...

(CNN) — A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human settlers first arrived on the country’s two main islands. Now, a ...